China’s one stop research shop
John Oyler has founded a string of startups in the US, including Genta, a biotech specializing in cancer drug discovery, and Galenea, which focuses on treatments for psychiatric diseases. But in 2005 he chose China as his base to launch BioDuro, a life sciences Contract Research Organisation (CRO). He explains to Chemistry World how he [...]
China CRO attracts $30m US investment
China’s second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer.
Headquartered in Shanghai, the firm counts large pharma companies such as Eli Lilly amongst its customers and is now looking to aggressively expand its offerings beyond chemistry outsourcing, into “more [...]
Bridge Announces the CRO Industry’s First China-US Visiting Scholar Program for Its Employees
Bridge Pharmaceuticals, Inc., a global leader in preclinical drug testing with facilities in the US and China, today announced initiation of a Visiting Scholar Program for its employees. This program will provide full support for qualified US employees to relocate and cross train in Bridge’s laboratories in Beijing, China or alternatively, for its qualified China [...]
China Trials 2009